Keywords: Reference change value; Biomarker of exposure; Smoke toxicant; Cigarette; Tobacco; Marker variability; Smoking; MRTP
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Tobacco harm reduction; Heat-not-burn; Modified risk tobacco product; Scientific assessment approach; MRTP; Modified Risk Tobacco Product; THS2.2; Tobacco Heating System version 2.2 regular; THS2.2M; Tobacco Heating System version 2.2 menthol version; HPH
Keywords: Modified risk tobacco product; Systems toxicology; Transcriptomics; Proteomics; Lipidomics; Subchronic inhalation toxicity; THS2.2; Tobacco Heating System 2.2; THS2.2M; mentholated THS2.2; HPHC; harmful and potentially harmful constituent; CS; cigarette s
Keywords: Tobacco heating system; Heat-not-Burn; THS 2.2; Indoor air quality; Harmful and potentially harmful constituent; Environmental aerosol; Environmental tobacco smoke; Nicotine; Carbonyls; Volatile organic compounds; BKG; Background; DNPH; 2,4-dinitrophenylh
Keywords: CCs; conventional cigarettes; COPD; chronic obstructive pulmonary disease; E-component; epidemiological risk component; ER; excess risk; ETS; environmental tobacco smoke; IHD; ischemic heart disease; LC; lung cancer; MRTP; Modified Risk Tobacco Products;
Keywords: BoE; biomarker of exposure; BoBE; biomarker of biological effect; BoED; biomarker of effective dose; FDA; Food and Drug Administration; IOM; Institute of Medicine; ISO; International Organisation for Standardisation; ISRCTN; International Standard Randomi
Keywords: Transendothelial migration; THP-1 cells; Endothelial cells; Atherosclerosis; Modified risk tobacco product; Tobacco-heating system; 7-AAD; 7-aminoactinomycin D; BSA; bovine serum albumin; CIM; cell invasion/migration; CXCL12; C-X-C motif ligand 12; HCAECs
Quantifying the risk-reduction potential of new Modified Risk Tobacco Products
Keywords: Smoking; Modeling; Modified risk tobacco product; Risk assessment; Biomarker; Translatability; Uncertainty; Monte Carlo; CC; cigarette consumption; ER; excess risk; HPHC; harmful and potentially harmful constituents; LOS; lack of sufficiency; MRTP; Modifi
In vitro systems toxicology-based assessment of the potential modified risk tobacco product CHTP 1.2 for vascular inflammation- and cytotoxicity-associated mechanisms promoting adhesion of monocytic cells to human coronary arterial endothelial cells
Keywords: Modified risk tobacco product; Cigarette; Monocyte; Endothelial cell; Adhesion; Atherosclerosis; 7-AAD; 7-Aminoactinomycin D; BIF; Biological Impact Factor; CFA; Cell Fate; CHTP; Carbon Heated Tobacco Product; CPR; Cell Proliferation; CS; Cigarette Smoke;
Evaluation of the tobacco heating system 2.2. Part 9: Application of systems pharmacology to identify exposure response markers in peripheral blood of smokers switching to THS2.2
Keywords: Smoking; Blood; Exposure response; Gene expression signature; Novel tobacco heating system; MRTP;
Systems toxicology-based assessment of the candidate modified risk tobacco product THS2.2 for the adhesion of monocytic cells to human coronary arterial endothelial cells
Keywords: CS; cigarette smoke; FDR; false discovery rate; HCAECs; human coronary artery endothelial cells; I, D, and FD; indirect, direct and fresh direct, respectively; ICAM-1; intercellular adhesion molecule 1; MM6; Mono Mac 6; MRTP; modified risk tobacco product